Welcome!

Open Source Authors: Liz McMillan, Lori MacVittie, Ali Hussain, Elizabeth White, Kevin Benedict

News Feed Item

Epilepsy Center Improves Sharing of Patient Data Using 100% Open Source WSO2 Carbon Enterprise Middleware and SUSE Linux

WSO2 today announced that The Epilepsy Institutes of the Netherlands Foundation (Stichting Epilepsie Instellingen Nederland, or SEIN), has implemented WSO2 Carbon enterprise middleware in combination with SUSE Linux to improve its information flow and integrate processes internally and externally with other organizations in the healthcare industry. The SEIN solution, which was implemented by WSO2 strategic partner Yenlo, includes WSO2 Enterprise Service Bus (WSO2 ESB), WSO2 API Manager (WSO2 API), and WSO2 Business Activity Monitor (WSO2 BAM).

The implementation was outlined in a new case study from WSO2, which can be downloaded at http://wso2.com/casestudies/epilepsy-center-improves-sharing-of-patient-data-with-wso2-carbon

Integrating Systems in the Highly Regulated Healthcare Industry

Based in Heemstede, the Netherlands, SEIN specializes in the diagnosis, treatment, support and research of epilepsy through its three clinical centers, 12 outpatient clinics, and other residential and special education facilities throughout the country. To perform the highly regulated exchange of information that allows SEIN to carry on its work—for example, sharing data with hospitals and insurance companies—SEIN asked Yenlo, WSO2’s world-wide implementation partner, to develop a solution for improving information flow and integrating processes.

The new case study from WSO2 examines the integration challenges facing SEIN, as well as the solution architecture Yenlo implemented for SEIN. Among the topics covered in the case study are:

  • The decision factors for deploying a 100% open source integration platform based on WSO2 ESB and SUSE Linux.
  • How the implementation enables SEIN to run critical business processes and manage patient information according to the requirements of the Health Level Seven (HL7) standard.
  • The role of WSO2 ESB in SEIN’s service-oriented architecture (SOA), serving as the central backbone for mediation and transformation.
  • The role of WSO2 API Manager in publishing APIs and managing developers’ access.
  • The use of WSO2 BAM to monitor the SEIN system’s performance metrics.

“The WSO2-SUSE combination implemented for us by Yenlo provides a centralized platform for exchanging data by integrating previously disparate information storage systems,” said Jean Willem Barzilay, chairman of the board of directors and responsible for all business units within SEIN. “Moreover, standardizing on open source software naturally entails cost reduction. From day one we have benefited from the user friendly solutions of WSO2 and SUSE.”

“We knew at the start that we wanted to build a solution for SEIN that could grow and adapt to its changing needs, while still adhering to strict requirements for the exchange of healthcare data,” said Ruben van der Zwan, CEO of Yenlo. “Using WSO2 Carbon enterprise middleware and SUSE Linux, we’ve met these goals, and today SEIN has a platform that offers the flexibility and ease of integration to address whatever the future may bring.”

“As one of the world’s leading institutes for the treatment and research of epilepsy, SEIN regularly coordinates processes with other healthcare organizations,” said Dr. Sanjiva Weerawarana, WSO2 founder and CEO. “We are thrilled by the success of Yenlo and SEIN in using our WSO2 Carbon enterprise middleware and SUSE Linux to securely integrate internal and third-party systems to facilitate SEIN’s online collaboration. It highlights the value of an open source, open standards approach to integrating the many systems that link processes across an enterprise’s ecosystem.”

About SEIN

The Epilepsy Institutes of the Netherlands Foundation (Stichting Epilepsie Instellingen Nederland, or SEIN) is a center of expertise for people with epilepsy and related disorders. SEIN specializes in diagnosis, treatment, support and research and from epilepsy. To make this possible, SEIN has three clinical centers, 12 outpatient clinics, residential facilities, special education and sleep centers. For more information, visit http://www.sein.nl.

About Yenlo

Founded in 2007, Yenlo is a Dutch-based software development and consulting company focused on middleware and business process management. Yenlo’s founders, who still act as members of the team, have an accumulated experience of over 35 years in IT with in-depth architectural knowledge in the areas of service-oriented computing, business process management and cloud computing. Working with a team of senior professionals, they deliver solutions to address the current and future business challenges on a global, worldwide scale. For more information, visit http://www.yenlo.com.

About WSO2

WSO2 is the only company that provides a completely integrated enterprise application platform for enabling a business to build and connect APIs, applications, Web services, iPaaS, PaaS, software as a service and legacy connections without having to write code; using big data and mobile; and fostering reuse through a social enterprise store. Only with WSO2 can enterprises use a family of governed secure solutions built on the same code base to extend their ecosystems across the cloud and on mobile devices to employees, customers and partners in anyway they like. Hundreds of leading enterprise customers across every sector—health, financial, retail, logistics, manufacturing, travel, technology, telecom and more—in every region of the world rely on WSO2’s award-winning, 100% open source platform for their mission-critical applications. To learn more, visit http://wso2.com, or check out the WSO2 community on the WSO2 Blog, Twitter, LinkedIn, and Facebook.

Trademarks and registered trademarks are the properties of their respective owners.

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.